159 related articles for article (PubMed ID: 15182826)
1. Adult acute myeloid leukaemia.
Smith M; Barnett M; Bassan R; Gatta G; Tondini C; Kern W
Crit Rev Oncol Hematol; 2004 Jun; 50(3):197-222. PubMed ID: 15182826
[TBL] [Abstract][Full Text] [Related]
2. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
3. Blood and marrow transplantation in elderly acute myeloid leukaemia patients - older certainly is not better.
Kiss TL; Sabry W; Lazarus HM; Lipton JH
Bone Marrow Transplant; 2007 Sep; 40(5):405-16. PubMed ID: 17572706
[TBL] [Abstract][Full Text] [Related]
4. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL
J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635
[TBL] [Abstract][Full Text] [Related]
5. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation.
Graef T; Vaupel M; Fenk R; Ruf L; Zohren F; Germing U; Haas R; Kobbe G
Hematol Oncol; 2007 Dec; 25(4):170-7. PubMed ID: 17579887
[TBL] [Abstract][Full Text] [Related]
7. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B
J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.
Tauro S; Craddock C; Peggs K; Begum G; Mahendra P; Cook G; Marsh J; Milligan D; Goldstone A; Hunter A; Khwaja A; Chopra R; Littlewood T; Peniket A; Parker A; Jackson G; Hale G; Cook M; Russell N; Mackinnon S
J Clin Oncol; 2005 Dec; 23(36):9387-93. PubMed ID: 16314618
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostics and therapy of acute myeloid leukemia].
Bornhäuser M; Ehninger G
Dtsch Med Wochenschr; 2009 Sep; 134(39):1935-41. PubMed ID: 19760554
[No Abstract] [Full Text] [Related]
11. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
12. Independent prognostic variables in acute myeloid leukaemia.
Smith ML; Hills RK; Grimwade D
Blood Rev; 2011 Jan; 25(1):39-51. PubMed ID: 21078537
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia.
Rubnitz JE; Gibson B; Smith FO
Pediatr Clin North Am; 2008 Feb; 55(1):21-51, ix. PubMed ID: 18242314
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression.
Junghanss C; Waak M; Knopp A; Kleine HD; Kundt G; Leithäuser M; Hilgendorf I; Wolff D; Casper J; Freund M
Neoplasma; 2005; 52(5):402-10. PubMed ID: 16151585
[TBL] [Abstract][Full Text] [Related]
16. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
Kebriaei P; Kline J; Stock W; Kasza K; Le Beau MM; Larson RA; van Besien K
Bone Marrow Transplant; 2005 May; 35(10):965-70. PubMed ID: 15806131
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of acute myeloid leukemia (AML) for medically non-fit patients].
Fritsch S; Buske C; Wörmann B; Wedding U; Hiddemann W; Spiekermann K
Med Klin (Munich); 2007 Apr; 102(4):324-9. PubMed ID: 17426936
[TBL] [Abstract][Full Text] [Related]
18. [Allogeneic stem cell transplantation in the management of acute myeloid leukemia].
Schmid C; Kolb HJ
Med Klin (Munich); 2007 Apr; 102(4):317-23. PubMed ID: 17426935
[TBL] [Abstract][Full Text] [Related]
19. Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation.
Claxton DF; Ehmann C; Rybka W
Br J Haematol; 2005 Jul; 130(2):256-64. PubMed ID: 16029454
[TBL] [Abstract][Full Text] [Related]
20. Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?
Song KW; Lipton J
Bone Marrow Transplant; 2005 Aug; 36(3):183-91. PubMed ID: 15937497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
